R. Yusen, Technology and Outcomes Assessment in Lung Transplantation, Proceedings of the American Thoracic Society, vol.6, issue.1, pp.128-136, 2009.
DOI : 10.1513/pats.200809-102GO

V. Costache, O. Chavanon, C. St-raymond, C. Sessa, M. Durand et al., Dramatic Improvement in Survival After Lung Transplantation Over Time: A Single Center Experience, Transplantation Proceedings, vol.41, issue.2, pp.687-691, 2009.
DOI : 10.1016/j.transproceed.2008.12.016

URL : https://hal.archives-ouvertes.fr/inserm-00387548

A. Boehler and M. Estenne, Post-transplant bronchiolitis obliterans, European Respiratory Journal, vol.22, issue.6, pp.1007-1018, 2003.
DOI : 10.1183/09031936.03.00039103

M. Dumonceaux, C. Knoop, B. Rondelet, and M. Estenne, Complications de la transplantation pulmonaire??: complications p??ri-op??ratoires, rejet aigu et chronique, Revue des Maladies Respiratoires, vol.26, issue.6, pp.639-653, 2009.
DOI : 10.1016/S0761-8425(09)74694-7

J. Christie, L. Edwards, P. Aurora, F. Dobbels, R. Kirk et al., The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report???2009, The Journal of Heart and Lung Transplantation, vol.28, issue.10, pp.1031-1049, 2009.
DOI : 10.1016/j.healun.2009.08.004

R. Hachem, Lung allograft rejection: diagnosis and management, Current Opinion in Organ Transplantation, vol.14, issue.5, 2009.
DOI : 10.1097/MOT.0b013e32832fb981

M. Estenne, J. Maurer, A. Boehler, J. Egan, A. Frost et al., Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria, The Journal of Heart and Lung Transplantation, vol.21, issue.3, pp.297-310, 2002.
DOI : 10.1016/S1053-2498(02)00398-4

M. Reynaud-gaubert, Pathophysiology of obliterative bronchiolitis in lung transplants], Rev Mal Respir, vol.20, issue.2, pp.224-232, 2003.

L. Sharples, K. Mcneil, S. Stewart, and J. Wallwork, Risk factors for bronchiolitis obliterans: a systematic review of recent publications, The Journal of Heart and Lung Transplantation, vol.21, issue.2, pp.271-281, 2002.
DOI : 10.1016/S1053-2498(01)00360-6

J. Belperio, S. Weigt, M. Fishbein, and J. Lynch, Chronic Lung Allograft Rejection: Mechanisms and Therapy, Proceedings of the American Thoracic Society, vol.6, issue.1, pp.108-121, 2009.
DOI : 10.1513/pats.200807-073GO

URL : http://doi.org/10.1513/pats.200807-073go

E. Grossman and R. Shilling, Bronchiolitis obliterans in lung transplantation: the good, the bad, and the future, Translational Research, vol.153, issue.4, pp.153-165, 2009.
DOI : 10.1016/j.trsl.2009.01.005

R. Shilling and D. Wilkes, Immunobiology of Chronic Lung Allograft Dysfunction: New Insights from the Bench and Beyond, American Journal of Transplantation, vol.10, issue.8, pp.1714-1718, 2009.
DOI : 10.1111/j.1600-6143.2009.02690.x

A. Magnan, J. Mege, J. Escallier, J. Brisse, C. Capo et al., Targeting allograft injury and inflammation in the management of post-lung transplant 24 Balance between alveolar macrophage IL-6 and TGF-beta in lung-transplant recipients

M. Marseille, . Lung-transplantation-group, G. Smith, J. Mickler, E. Payne et al., Lung transplant metalloproteinase levels are elevated prior to bronchiolitis obliterans syndrome, Am J Respir Crit Care Med Am J Transplant, vol.1537, issue.257, pp.1431-14361856, 1996.

R. Hubner, S. Meffert, U. Mundt, H. Bottcher, S. Freitag et al., Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation, European Respiratory Journal, vol.25, issue.3, pp.494-501, 2005.
DOI : 10.1183/09031936.05.00091804

B. Magi, E. Bargagli, L. Bini, and P. Rottoli, Proteome analysis of bronchoalveolar lavage in lung diseases, PROTEOMICS, vol.287, issue.23, pp.6354-6369, 2006.
DOI : 10.1002/pmic.200600303

R. Bowler, M. Ellison, and N. Reisdorph, Proteomics in Pulmonary Medicine, Chest, vol.130, issue.2, pp.567-574, 2006.
DOI : 10.1378/chest.130.2.567

R. Wattiez and P. Falmagne, Proteomics of bronchoalveolar lavage fluid, Journal of Chromatography B, vol.815, issue.1-2, pp.169-178, 2005.
DOI : 10.1016/j.jchromb.2004.10.029

I. Noel-georis, A. Bernard, P. Falmagne, and R. Wattiez, Database of bronchoalveolar lavage fluid proteins, Journal of Chromatography B, vol.771, issue.1-2, pp.221-236, 2002.
DOI : 10.1016/S1570-0232(02)00114-9

R. Wattiez, C. Hermans, C. Cruyt, A. Bernard, and P. Falmagne, Human bronchoalveolar lavage fluid protein two-dimensional database: Study of interstitial lung diseases, Electrophoresis, vol.67, issue.6, pp.2703-2712, 2000.
DOI : 10.1002/1522-2683(20000701)21:13<2703::AID-ELPS2703>3.0.CO;2-W

C. De-torre, S. Ying, P. Munson, G. Meduri, and A. Suffredini, Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage, PROTEOMICS, vol.22, issue.38, pp.3949-3957, 2006.
DOI : 10.1002/pmic.200500693

E. Kriegova, C. Melle, V. Kolek, B. Hutyrova, F. Mrazek et al., Protein Profiles of Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.10, pp.1145-1154, 2006.
DOI : 10.1164/rccm.200507-1126OC

D. Merkel, W. Rist, P. Seither, A. Weith, and M. Lenter, Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification, PROTEOMICS, vol.23, issue.5, pp.2972-2980, 2005.
DOI : 10.1002/pmic.200401180

B. Mcmorran, S. Patat, J. Carlin, K. Grimwood, A. Jones et al., Novel Neutrophil-Derived Proteins in Bronchoalveolar Lavage Fluid Indicate an Exaggerated Inflammatory Response in Pediatric Cystic Fibrosis Patients, Clinical Chemistry, vol.53, issue.10, pp.1782-1791, 2007.
DOI : 10.1373/clinchem.2007.087650

G. Macgregor, R. Gray, T. Hilliard, M. Imrie, A. Boyd et al., Biomarkers for cystic fibrosis lung disease: Application of SELDI-TOF mass spectrometry to BAL fluid Surface enhanced laser desorption/ionization (SELDI) time-of-flight mass spectrometry to identify patients with chronic obstructive pulmonary disease, J Cyst Fibros Copd, vol.373, issue.1, pp.41-50, 2006.

S. Bozinovski, A. Hutchinson, M. Thompson, L. Macgregor, J. Black et al., Serum Amyloid A Is a Biomarker of Acute Exacerbations of Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.3, pp.269-278, 2008.
DOI : 10.1164/rccm.200705-678OC

R. Gray, G. Macgregor, D. Noble, M. Imrie, M. Dewar et al., Sputum Proteomics in Inflammatory and Suppurative Respiratory Diseases, American Journal of Respiratory and Critical Care Medicine, vol.178, issue.5, pp.444-452, 2008.
DOI : 10.1164/rccm.200703-409OC

B. Nicholas, P. Skipp, R. Mould, S. Rennard, D. Davies et al., Shotgun proteomic analysis of human-induced sputum, PROTEOMICS, vol.152, issue.15, pp.4390-4401, 2006.
DOI : 10.1002/pmic.200600011

M. Fumagalli, L. Dolcini, A. Sala, J. Stolk, L. Fregonese et al., Proteomic analysis of exhaled breath condensate from single patients with pulmonary emphysema associated to ??1-antitrypsin deficiency, Journal of Proteomics, vol.71, issue.2, pp.211-221, 2008.
DOI : 10.1016/j.jprot.2008.03.002

T. Poon, Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices, Expert Review of Proteomics, vol.4, issue.1, pp.51-65, 2007.
DOI : 10.1586/14789450.4.1.51

M. Kiehntopf, R. Siegmund, and T. Deufel, Abstract, Clinical Chemical Laboratory Medicine, vol.45, issue.11, pp.1435-1449, 2007.
DOI : 10.1515/CCLM.2007.351

Z. Zhang, R. Bast, J. Yu, Y. Li, J. Sokoll et al., Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer, Cancer Research, vol.64, issue.16, pp.5882-5890, 2004.
DOI : 10.1158/0008-5472.CAN-04-0746

D. Petris, L. Orre, L. Kanter, L. Pernemalm, M. Koyi et al., Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer, Lung Cancer, vol.63, issue.3, pp.410-417, 2009.
DOI : 10.1016/j.lungcan.2008.06.003

S. Ocak, M. Sos, R. Thomas, and P. Massion, High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications, European Respiratory Journal, vol.34, issue.2, pp.489-506, 2009.
DOI : 10.1183/09031936.00042409

D. De-seny, M. Fillet, M. Meuwis, P. Geurts, L. Lutteri et al., Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach, Arthritis & Rheumatism, vol.5, issue.12, pp.3801-3812, 2005.
DOI : 10.1002/art.21607

D. De-seny, M. Fillet, C. Ribbens, R. Maree, M. Meuwis et al., Monomeric Calgranulins Measured by SELDI-TOF Mass Spectrometry and Calprotectin Measured by ELISA as Biomarkers in Arthritis, Clinical Chemistry, vol.54, issue.6, pp.1066-1075, 2008.
DOI : 10.1373/clinchem.2007.099549

G. Nelsestuen, M. Martinez, M. Hertz, K. Savik, and C. Wendt, Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection, PROTEOMICS, vol.142, issue.6, pp.1705-1713, 2005.
DOI : 10.1002/pmic.200401036

S. Stewart, M. Fishbein, G. Snell, G. Berry, A. Boehler et al., Revision of the 1996 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Lung Rejection, The Journal of Heart and Lung Transplantation, vol.26, issue.12, pp.1229-1242, 2007.
DOI : 10.1016/j.healun.2007.10.017

P. Haslam and R. Baughman, Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL, European Respiratory Journal, vol.14, issue.2, pp.245-248, 1999.
DOI : 10.1034/j.1399-3003.1999.14b01.x

S. Hu, J. Loo, and D. Wong, Human body fluid proteome analysis, PROTEOMICS, vol.109, issue.23, pp.6326-6353, 2006.
DOI : 10.1002/pmic.200600284

A. Plymoth, C. Lofdahl, A. Ekberg-jansson, M. Dahlback, H. Lindberg et al., Human bronchoalveolar lavage: Biofluid analysis with special emphasis on sample preparation, PROTEOMICS, vol.3, issue.6, pp.962-972, 2003.
DOI : 10.1002/pmic.200300387

A. Lenz, B. Meyer, H. Weber, and K. Maier, Two-dimensional electrophoresis of dog bronchoalveolar lavage fluid proteins, Electrophoresis, vol.13, issue.6, pp.510-513, 1990.
DOI : 10.1002/elps.1150110616

J. Roth, T. Vogl, C. Sorg, and C. Sunderkotter, Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules, Trends in Immunology, vol.24, issue.4, pp.155-158, 2003.
DOI : 10.1016/S1471-4906(03)00062-0

D. Foell, M. Frosch, C. Sorg, and R. J. , Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation, Clinica Chimica Acta, vol.344, issue.1-2, pp.37-51, 2004.
DOI : 10.1016/j.cccn.2004.02.023

C. Ryckman, K. Vandal, P. Rouleau, M. Talbot, and P. Tessier, Proinflammatory Activities of S100: Proteins S100A8, S100A9, and S100A8/A9 Induce Neutrophil Chemotaxis and Adhesion, The Journal of Immunology, vol.170, issue.6, pp.3233-3242, 2003.
DOI : 10.4049/jimmunol.170.6.3233

S. Berthier, M. Paclet, S. Lerouge, F. Roux, S. Vergnaud et al., Changing the conformation state of cytochrome b558 initiates NADPH oxidase activation
URL : https://hal.archives-ouvertes.fr/hal-00313172

D. Foell, H. Wittkowski, T. Vogl, and R. J. , S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules, Journal of Leukocyte Biology, vol.81, issue.1, pp.28-37, 2007.
DOI : 10.1189/jlb.0306170

A. Ahmad, D. Bayley, S. He, and R. Stockley, Myeloid Related Protein-8/14 Stimulates Interleukin-8 Production in Airway Epithelial Cells, American Journal of Respiratory Cell and Molecular Biology, vol.29, issue.4, pp.523-530, 2003.
DOI : 10.1165/rcmb.2002-0286OC

E. Lorenz, M. Muhlebach, P. Tessier, N. Alexis, D. Hite et al., Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases, Respiratory Medicine, vol.102, issue.4, pp.567-573, 2008.
DOI : 10.1016/j.rmed.2007.11.011

S. Tirkos, S. Newbigging, V. Nguyen, M. Keet, C. Ackerley et al., Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulator, Respiratory Research, vol.90, issue.12, p.51, 2006.
DOI : 10.1186/1465-9921-7-51

D. Foell, S. Seeliger, T. Vogl, H. Koch, H. Maschek et al., Expression of S100A12 (EN-RAGE) in cystic fibrosis, Thorax, vol.58, issue.7, pp.613-617, 2003.
DOI : 10.1136/thorax.58.7.613

B. Golden, P. Clohessy, G. Russell, and M. Fagerhol, Calprotectin as a marker of inflammation in cystic fibrosis., Archives of Disease in Childhood, vol.74, issue.2, pp.136-139, 1996.
DOI : 10.1136/adc.74.2.136

R. Bals, Epithelial antimicrobial peptides in host defense against infection, Respiratory Research, vol.13, issue.3, pp.141-150, 2000.
DOI : 10.1146/annurev.iy.13.040195.000425

R. Bals and P. Hiemstra, Innate immunity in the lung: how epithelial cells fight against respiratory pathogens, European Respiratory Journal, vol.23, issue.2, pp.327-333, 2004.
DOI : 10.1183/09031936.03.00098803

T. Ganz, Defensins: antimicrobial peptides of innate immunity, Nature Reviews Immunology, vol.3, issue.9, pp.651-656, 1999.
DOI : 10.1038/nri1180

S. Van-wetering, G. Tjabringa, and P. Hiemstra, Interactions between neutrophil-derived antimicrobial peptides and airway epithelial cells, Journal of Leukocyte Biology, vol.77, issue.4, pp.444-450, 2005.
DOI : 10.1189/jlb.0604367

R. Anderson, P. Hiemstra, C. Ward, I. Forrest, D. Murphy et al., Pulmonary Antimicrobial Peptides in Lung Transplant Recipients with Bronchiolitis Obliterans Syndrome, Eur Respir J, p.42, 2008.